01/16/2025
4:59 PM | BILINSKY IGOR (Reporting)
Iovance Biotherapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/16/2025
5:00 PM | GRAF FINCKENSTEIN FRIEDRICH (Reporting)
Iovance Biotherapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/16/2025
5:01 PM | Iovance Biotherapeutics (Issuer)
Vogt Frederick G (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/18/2024
4:15 PM | Iovance Biotherapeutics (Issuer)
Puri Raj K. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/13/2024
4:16 PM | Iovance Biotherapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
12/02/2024
4:25 PM | Iovance Biotherapeutics (Issuer)
Puri Raj K. (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
11/21/2024
4:15 PM | Iovance Biotherapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/14/2024
3:50 PM | Iovance Biotherapeutics (Subject)
PERCEPTIVE ADVISORS LLC (Filed by)
| Form SC 13G/A | |
11/12/2024
6:11 PM | Iovance Biotherapeutics (Subject)
Maynard Ryan D (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/07/2024
8:03 PM | Iovance Biotherapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/07/2024
4:15 PM | Iovance Biotherapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
|
10/18/2024
7:38 AM | Iovance Biotherapeutics (Subject)
STATE STREET CORP (Filed by)
| Form SC 13G/A | |
10/16/2024
5:30 PM | BILINSKY IGOR (Reporting)
Iovance Biotherapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/16/2024
5:32 PM | GRAF FINCKENSTEIN FRIEDRICH (Reporting)
Iovance Biotherapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/16/2024
5:33 PM | Iovance Biotherapeutics (Issuer)
Vogt Frederick G (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/05/2024
6:52 PM | Bellemin Jean-Marc (Reporting)
Iovance Biotherapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/05/2024
6:53 PM | BILINSKY IGOR (Reporting)
Iovance Biotherapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/05/2024
6:54 PM | GRAF FINCKENSTEIN FRIEDRICH (Reporting)
Iovance Biotherapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/05/2024
6:56 PM | Iovance Biotherapeutics (Issuer)
Vogt Frederick G (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/09/2024
4:16 PM | Iovance Biotherapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/08/2024
4:10 PM | Iovance Biotherapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
07/17/2024
7:00 PM | BILINSKY IGOR (Reporting)
Iovance Biotherapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/17/2024
7:01 PM | GRAF FINCKENSTEIN FRIEDRICH (Reporting)
Iovance Biotherapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/17/2024
7:01 PM | Iovance Biotherapeutics (Issuer)
Vogt Frederick G (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/28/2024
6:30 AM | Iovance Biotherapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/13/2024
5:00 PM | Dukes Iain D. (Reporting)
Iovance Biotherapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/13/2024
5:00 PM | Iovance Biotherapeutics (Issuer)
Maynard Ryan D (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/13/2024
5:01 PM | Iovance Biotherapeutics (Issuer)
WEISER MICHAEL (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/13/2024
5:02 PM | Iovance Biotherapeutics (Issuer)
YARNO WENDY L (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/13/2024
5:03 PM | Countouriotis Athena (Reporting)
Iovance Biotherapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/11/2024
4:15 PM | Iovance Biotherapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/05/2024
7:07 PM | GRAF FINCKENSTEIN FRIEDRICH (Reporting)
Iovance Biotherapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/05/2024
7:04 PM | Iovance Biotherapeutics (Issuer)
Vogt Frederick G (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/05/2024
7:05 PM | BILINSKY IGOR (Reporting)
Iovance Biotherapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/03/2024
7:01 AM | Iovance Biotherapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/17/2024
4:15 PM | Iovance Biotherapeutics (Filer)
| Form DEFA14A | |
05/01/2024
4:05 PM | Iovance Biotherapeutics (Filer)
| Form ARS | |
04/29/2024
4:06 PM | Iovance Biotherapeutics (Filer)
| Form DEF 14A | |
04/29/2024
4:07 PM | Iovance Biotherapeutics (Filer)
| Form DEFA14A | |
04/17/2024
6:07 PM | BILINSKY IGOR (Reporting)
Iovance Biotherapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/17/2024
6:07 PM | GRAF FINCKENSTEIN FRIEDRICH (Reporting)
Iovance Biotherapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
Wall St turns to THIS catalyst after Trump’s inauguration (Ad) Wall Street is already looking past Trump…
To a new catalyst on the near horizon that could be even bigger than his inauguration.
As soon as January 29th… So please watch this video now before the hammer falls and it’s too late. |
04/17/2024
6:08 PM | Iovance Biotherapeutics (Issuer)
Vogt Frederick G (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/29/2024
4:00 PM | Iovance Biotherapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/06/2024
5:19 PM | Iovance Biotherapeutics (Issuer)
Vogt Frederick G (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/06/2024
5:20 PM | GRAF FINCKENSTEIN FRIEDRICH (Reporting)
Iovance Biotherapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/06/2024
5:17 PM | BILINSKY IGOR (Reporting)
Iovance Biotherapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/05/2024
4:58 PM | Iovance Biotherapeutics (Issuer)
YARNO WENDY L (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/05/2024
4:50 PM | Countouriotis Athena (Reporting)
Iovance Biotherapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/05/2024
4:51 PM | Bellemin Jean-Marc (Reporting)
Iovance Biotherapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/05/2024
4:52 PM | BILINSKY IGOR (Reporting)
Iovance Biotherapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/04/2024
7:00 AM | Iovance Biotherapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/01/2024
6:09 PM | Iovance Biotherapeutics (Subject)
PERCEPTIVE ADVISORS LLC (Filed by)
| Form SC 13G | |
02/29/2024
6:30 AM | Iovance Biotherapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/28/2024
3:05 PM | Iovance Biotherapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/21/2024
3:44 PM | Iovance Biotherapeutics (Filer)
| Form 424B5 | |
02/20/2024
6:52 PM | Iovance Biotherapeutics (Issuer)
MCPEAK MERRILL A (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/20/2024
4:23 PM | Iovance Biotherapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/20/2024
5:03 AM | Iovance Biotherapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/14/2024
5:16 AM | Iovance Biotherapeutics (Subject)
Point72 Asset Management, L.P. (Filed by)
| Form SC 13G/A | |
02/09/2024
4:40 PM | Iovance Biotherapeutics (Subject)
MHR FUND MANAGEMENT LLC (Filed by)
| Form SC 13G/A | |
01/25/2024
9:49 AM | Iovance Biotherapeutics (Subject)
STATE STREET CORP (Filed by)
| Form SC 13G/A | |
Free IOVA Stock Alerts